tirzepatide clinical trial weight loss results surmount-1 Analysis of Acquisition Costs and Reduction Outcomes in the United Kingdom: Insights from the Study Tirzepatide for Weight Loss |

Canadas FDA equivalent, Health Canada, has already approved two generic versions of Ozempic and is reviewing submissions for seven others, according to a May 1 press release

ZEPBOUND has not been studied in patients with severe gastrointestinal disease, including severe gastroparesis, and is therefore not recommended in these patients

However, kidney function should be monitored closely, especially if dehydration occurs

Public plans spent $794-million on Ozempic in 2024, according to the most recent data

Estrogen in the brain is part of the picture: The hypothalamus is the region of the brain responsible for maintaining a stable body temperature through a series of feedback systems